CCR5 is expressed on most CD8+ T cells, monocytes and macrophages within inflammatory MS lesions; it could, therefore, contribute to recruitment of these cells to the inflamed tissue, their activation and/or their survival [99]. Here, CCR5 is linked to myeloid sarcoma.